Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
企業コードVTAK
会社名Catheter Precision Inc
上場日Sep 27, 2018
最高経営責任者「CEO」Jenkins (David A)
従業員数22
証券種類Ordinary Share
決算期末Sep 27
本社所在地1670 Highway 160 West
都市FORT MILL
証券取引所NASDAQ OMX – NASDAQ Basic Amex
国United States of America
郵便番号29708
電話番号19736912000
ウェブサイトhttps://www.ramed.com/
企業コードVTAK
上場日Sep 27, 2018
最高経営責任者「CEO」Jenkins (David A)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし